DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure

British Journal of Cancer

Volumn 100, Issue 8, 2009, Pages 1336-1342

  Kettunen, E ^a   Aavikko, M ^a   Nymark, P ^a,b   Ruosaari, S ^a,c   Wikman, H ^b   Vanhala, E ^a   Salmenkivi, K ^b   Pirinen, R ^d   Karjalainen, A ^a   Kuosma, E ^a   Anttila, S ^a,b  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HELSINKI INSTITUTE FOR INFORMATION TECHNOLOGY   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Allelic imbalance; Asbestos exposure; Genetic marker; Lung cancer

Indexed keywords

ASBESTOS; DNA;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 2P; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; GENE NUMBER; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; ASBESTOS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 64949189973     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605012     Document Type: Article

References (28)

1. Andersen CL, Hostetter G, Grigoryan A, Sauter G, Kallioniemi A (2001) Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 45: 83-86
2. Chin S, Daigo Y, Huang H, Iyer N, Callagy G, Kranjac T, Gonzalez M, Sangan T, Earl H, Caldas C (2003) A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue micro-arrays of paraffin wax embedded tumour samples. Mol Pathol 56: 275-279
3. Consensus report (1997) Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 23: 311-316
4. Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S, Simansky D, Krupsky M, Yaron P, Friedman E, Rechavi G, Perlman M, Aviram-Goldring A, Izraeli S, Bittner M, Yakhini Z, Kaminski N (2007) Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung cancer 56: 175-184
5. Dopp E, Schiffmann D (1998) Analysis of chromosomal alterations induced by asbestos and ceramic fibers. Toxicol Lett 96-97: 155-162
6. Henderson DW, Rödelsperger K, Woitowitz HJ, Leigh J (2004) After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology 36: 517-550
7. Karjalainen A, Anttila S, Heikkilä L, Karhunen P, Vainio H (1993) Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am J Ind Med 23: 461-471
8. Karjalainen A, Anttila S, Vanhala E, Vainio H (1994) Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 20: 243-250
9. Kettunen E, El-Rifai W, Björkqvist AM, Wolff H, Karjalainen A, Anttila S, Mattson K, Husgafvel-Pursiainen K, Knuutila S (2000) A broad amplification pattern at 3q in squamous cell lung cancer - a fluorescence in situ hybridization study. Cancer Genet Cytogenet 117: 66-70
10. Kim YH, Girard L, Giacomini CP, Wang P, Hernandez-Boussard T, Tibshirani R, Minna JD, Pollack JR (2006) Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25: 130-138
11. Knuutila S (2004) Amplicons: Respiratory tract tumors. http://www.infobiogen.fr/services/chromcancer/Ampl/Resp.html. Atlas Genet Cytogenet Oncol Haematol
12. Koivunen JP, Mermel C, Zejnullahu K, Murphy C, Lifshits E, Holmes AJ, Choi HG, Kim J, Chiang D, Thomas R, Lee J, Richards WG, Sugarbaker DJ, Ducko C, Lindeman N, Marcoux JP, Engelman JA, Gray NS, Lee C, Meyerson M, Jänne PA (2008) EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 14: 4275-4283
13. La Dou J (2004) The asbestos cancer epidemic. Environ Health Perspect 112: 285-290
14. Matyakhina L, Pack S, Kirschner LS, Pak E, Mannan P, Jaikumar J, Taymans SE, Sandrini F, Carney JA, Stratakis CA (2003) Chromosome 2 (2p16) abnormalities in Carney complex tumours. J Med Genet 40: 268-277
15. Miserocchi G, Sancini G, Mantegazza F, Chiappino G (2008) Translocation pathways for inhaled asbestos fibers. Environ Health 7: 4
16. Mitelman F, Johansson B, Mertens F (2009) Mitelman Database of Chromosome Aberrations in Cancer, http://cgap.nci.nih.gov/Chromosomes/ Mitelman
17. Nymark P, Kettunen E, Aavikko M, Ruosaari S, Kuosma E, Vanhala E, Salmenkivi K, Pirinen R, Karjalainen A, Knuutila S, Wikman H, Anttila S (2009) Molecular alterations at 9q33.1 and polyploidy in asbestos-related lung cancer. Clin Cancer Res 15: 468-475
18. Nymark P, Lindholm P, Korpela M, Lahti L, Ruosaari S, Kaski S, Hollmen J, Anttila S, Kinnula V, Knuutila S (2007) Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines. BMC Genomics 8: 62
19. Nymark P, Wikman H, Ruosaari S, Hollmén J, Vanhala E, Karjalainen A, Anttila S, Knuutila S (2006) Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res 16: 5737-5743
20. Okayasu R, Takahashi S, Yamada S, Hei TK, Ullrich RL (1999) Asbestos and DNA double strand breaks. Cancer Res 59: 298-300
21. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
22. Peto R (1994) Smoking and death: the past 40 years and the next 40. BMJ 309: 937-939
23. Ruosaari ST, Nymark PEH, Aavikko MM, Kettunen E, Knuutila S, Hollmen J, Norppa H, Anttila SL (2008) Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro. Carcinogenesis 29: 913-917
24. Schwartz M, Zlotorynski E, Kerem B (2006) The molecular basis of common and rare fragile sites. Cancer Lett 232: 13-26
25. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S-i, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566
26. Unfried K, Schurkes C, Abel J (2002) Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res 62: 99-104
27. Wikman H, Ruosaari S, Nymark P, Sarhadi VK, Saharinen J, Vanhala E, Karjalainen A, Hollmén J, Knuutila S, Anttila S (2007) Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer. Oncogene 26: 4730-4737
28. Xu A, Wu L-J, Santella RM, Hei TK (1999) Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells. Cancer Res 59: 5922-5926